Clinical Trial Update: A Study to Assess Efficacy and Safety of N-Acetyl-GED-0507-34-LEVO Gel 5%, in Patients With Acne Vulgaris (GEDACNE-1) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the efficacy and safety of N-Acetyl-GED-0507-34-LEVO Gel 5% for acne vulgaris; the study is active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• N-Acetyl-GED-0507-34-LEVO Gel 5%

Snippet

Sponsor: PPM Services S.A. | Conditions: Acne Vulgaris | Phase 3 | Status: ACTIVE_NOT_RECRUITING